128 related articles for article (PubMed ID: 36621036)
21. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
[TBL] [Abstract][Full Text] [Related]
22. Increasing uptake to a lung cancer screening programme: building with communities through co-design.
Brown LR; Sullivan F; Treweek S; Haddow A; Mountain R; Selby C; Beusekom MV
BMC Public Health; 2022 Apr; 22(1):815. PubMed ID: 35461289
[TBL] [Abstract][Full Text] [Related]
23. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
24. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
[TBL] [Abstract][Full Text] [Related]
25. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
26. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract][Full Text] [Related]
27. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
[No Abstract] [Full Text] [Related]
29. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
30. Patient Identification of Lung Cancer Screening Follow-Up Recommendations and the Association with Adherence.
Triplette M; Wenger DS; Shahrir S; Kross EK; Kava C; Phipps A; Hawes SE; Cole A; Snidarich M; Crothers K
Ann Am Thorac Soc; 2022 May; 19(5):799-806. PubMed ID: 34727513
[No Abstract] [Full Text] [Related]
31. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
[TBL] [Abstract][Full Text] [Related]
32. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
[TBL] [Abstract][Full Text] [Related]
34. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.
Kim RY; Rendle KA; Mitra N; Saia CA; Neslund-Dudas C; Greenlee RT; Burnett-Hartman AN; Honda SA; Simoff MJ; Schapira MM; Croswell JM; Meza R; Ritzwoller DP; Vachani A
Ann Am Thorac Soc; 2022 Sep; 19(9):1561-1569. PubMed ID: 35167781
[No Abstract] [Full Text] [Related]
35. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
36. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
37. Initial results of a lung cancer screening demonstration project: a local program evaluation.
Fabbrini AE; Lillie SE; Partin MR; Fu SS; Clothier BA; Bangerter AK; Nelson DB; Doro EA; Bell BJ; Rice KL
Am J Manag Care; 2018 Jun; 24(6):272-277. PubMed ID: 29939501
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History.
Maller B; Simmons VN; Byrne MM; Tanvetyanon T
Clin Lung Cancer; 2021 Jul; 22(4):e629-e636. PubMed ID: 33441268
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
40. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
